Jichan Shi
Wenzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Rifapentine dosing for drug-susceptible tuberculosis: stage 1 of a seamless phase 2/3 randomized clinical trial.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: January 22, 2026
QT interval prolongation and cardiotoxicity in shorter regimens for rifampicin-resistant tuberculosis.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: January 16, 2026
A QuantiFERON®-TB Gold Plus-Based Model for Predicting Latent Tuberculosis Infection in Patients with Diabetes.
Journal: Infection and drug resistance
Published: November 28, 2025
Evaluation of nucleic acid-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for rapid identification of Mycobacterium tuberculosis and drug resistance in patients with retreatment tuberculosis.
Journal: Frontiers in microbiology
Published: August 28, 2025
A 6- to 9-months oral regimen for rifampicin-resistant tuberculosis: a randomized open-label noninferiority trial in China.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: August 14, 2025
Corrigendum to "Integrated transcriptomics and metabolomics unravel the key metabolic pathways involved in the therapeutic mechanism of Salvianic acid A against hepatic fibrosis" [Toxicology and Applied Pharmacology 500 (2025) 117398].
Journal: Toxicology and applied pharmacology
Published: June 20, 2025
Acquired resistance during short-course treatment for rifampicin-resistant tuberculosis.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: April 14, 2025
A Short, All-oral Regimen for Pre-extensively Drug-resistant Tuberculosis: A Multicenter Open-label Single-arm Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 08, 2024
Clinical Efficacy of Continuous Renal Replacement Therapy in Patients with Pulmonary Tuberculosis Complicated with Sepsis: A Retrospective Observational Study.
Journal: Infection and drug resistance
Published: November 06, 2024
Diagnostic value of GeneXpert MTB/RIF in bronchoalveolar lavage fluid for pulmonary non-tuberculosis mycobacterial in acid-fast stain smear-positive and GeneXpert MTB/RIF-negative cases.
Journal: Journal of thoracic disease
Published: September 19, 2024
Evaluation of WHO catalog of mutations and five WGS analysis tools for drug resistance prediction of Mycobacterium tuberculosis isolates from China.
Journal: Microbiology spectrum
Published: June 21, 2024
Last Updated: 09/26/2026